Surmodics, Inc. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8ad07979-8cd6-4619-a714-e74d01f4a8df/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-5.6M | 2023-10-01 – 2024-09-30 | evidence 0000950170-24-129020 |
| FY 2023 | $5.2M | 2022-10-01 – 2023-09-30 | evidence 0000950170-23-065738 |
| FY 2022 | $-22.1M | 2021-10-01 – 2022-09-30 | evidence 0000950170-22-025644 |
| FY 2021 | $6.7M | 2020-10-01 – 2021-09-30 | evidence 0001564590-21-058206 |
| FY 2020 | $-1.3M | 2019-10-01 – 2020-09-30 | evidence 0001564590-20-055870 |
| FY 2019 | $6.5M | 2018-10-01 – 2019-09-30 | evidence 0001564590-19-045173 |
| FY 2018 | $-8.8M | 2017-10-01 – 2018-09-30 | evidence 0001564590-18-030336 |
| FY 2017 | $7.1M | 2016-10-01 – 2017-09-30 | evidence 0001564590-17-024465 |
| FY 2016 | $16.9M | 2015-10-01 – 2016-09-30 | evidence 0001564590-16-029755 |
| FY 2015 | $19.1M | 2014-10-01 – 2015-09-30 | evidence 0001564590-15-011278 |
| FY 2014 | $18.6M | 2013-10-01 – 2014-09-30 | evidence 0001193125-14-434817 |
| FY 2013 | $18.8M | 2012-10-01 – 2013-09-30 | evidence 0001193125-13-469798 |
| FY 2012 | $16.3M | 2011-10-01 – 2012-09-30 | evidence 0001193125-12-503216 |
| FY 2011 | $15.5M | 2010-10-01 – 2011-09-30 | evidence 0001193125-12-503216 |
| FY 2010 | $12.0M | 2009-10-01 – 2010-09-30 | evidence 0001193125-12-503216 |
| FY 2009 | $57.5M | 2008-10-01 – 2009-09-30 | evidence 0001193125-11-341075 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).